ÂÜÀòÂÒÂ×

Navega Therapeutics has developed a patented, non-permanent gene therapy to target pain that is non-addictive, highly specific, and long-lasting. Navega Therapeutics has imitated this process by utilizing a novel gene therapy to target pain in a non-permanent way.